Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Theresa May is considering options to secure statutory powers for child sex abuse inquiry but it may require 'disbanding' current panel.
London mayor Boris Johnson is backing Olympics supremo Seb Coe as his replacement.
A top Fifa official who assessed rival bids to stage the 2018 and 2022 World Cups revealed England’s was by far the strongest contender.